Reduction of daunorubicin in the presence of sulfur-containing peptides.
Daunorubicin, an anthracycline antitumor antibiotic, was reduced in the presence of reduced (GSH) or oxidized (GSSG) glutathione to evaluate the possibilities of detoxification or of potentiation of the drug by these compounds. The reductants were .COO- free radicals produced by gamma radiolysis. In both cases, the final product is 7-deoxydaunomycinone, i.e., the same as without glutathione. The reduction yield is also the same as without GSH or GSSG (0.23 mumol.J-1). No glutathione depletion was observed. Limits for the rate constants of some possible nonenzymatic detoxification reactions are given. To evaluate the possible interactions of daunorubicin with sulfur-containing proteins, the reduction of this drug by .COO- free radicals was also studied in the presence of a polypeptide containing two disulfide bridges, aponeocarzinostatine. The final product is also 7-deoxydaunomycinone. The yields of reduction of the drug and of a protein disulfide bridge are, respectively, 0.23 mumol.J-1 and less than or equal to 6 nmol.J-1. These values indicate that disulfide radical anions of the protein can reduce the drug, giving back the disulfide bridge, but that the drug transients neither oxidize nor reduce the protein.
Houée-Levin
C
C
Laboratoire de Chimie Physique, Université Paris V, France.
Benzineb
K
K
Gardès-Albert
M
M
Abedinzadeh
Z
Z
Ferradini
C
C
D001059:Apoproteins / Q000737:chemistry*; D003630:Daunorubicin / Q000737:chemistry*; D004220:Disulfides / Q000737:chemistry; D005609:Free Radicals; D005978:Glutathione / Q000737:chemistry; D007700:Kinetics; D010084:Oxidation-Reduction; D010455:Peptides / Q000737:chemistry*; D013438:Sulfhydryl Compounds / Q000737:chemistry; D009353:Zinostatin / Q000737:chemistry*
D001059:Apoproteins; D004220:Disulfides; D005609:Free Radicals; D010455:Peptides; D013438:Sulfhydryl Compounds; C052401:aponeocarzinostatin; D009353:Zinostatin; D005978:Glutathione; D003630:Daunorubicin